Minimally Invasive Synchronous Cardiac Assisted Pump and in Vitro study

Heart failure is the end-stage manifestation of various heart diseases, which has high morbidity and mortality. Mechanical circulatory support (MCS) is a required clinical treatment method. This study developed a new MCS, minimally invasive synchronized cardiac assist pump (ISCAP). The ISCAP works in synchronization with the heart to reduce afterload and increase cardiac output. An in vitro experimental platform for simulating heart failure designed to study the effect of ISCAP. The experimental results show that compared to the Intra-aortic balloon pump (IABP), ISCAP is more effective in increasing cardiac output and reducing systolic and diastolic blood pressure, thereby having better hemodynamic parameters.